
G.F.C Green Fields Capital Ltd. GFC-M.TA
GFC-M.TA
G.F.C Green Fields Capital Ltd. DNA.TA
Dna Group (T.R.) Ltd KDST.TA
Kadimastem Ltd PLUR.TA
Pluri Inc. REKA.TA
Rekah Pharmaceutical Industry Ltd. ENLV.TA
Enlivex Therapeutics Ltd. CBI.TA
Clal Biotechnology Industries Ltd. GEFR.TA
Geffen Residence & Renewal Ltd BLRX.TA
BioLineRx Ltd. CANF.TA
Can-Fite BioPharma Ltd.
G.F.C Green Fields Capital Ltd. DNA.TA
Dna Group (T.R.) Ltd KDST.TA
Kadimastem Ltd PLUR.TA
Pluri Inc. REKA.TA
Rekah Pharmaceutical Industry Ltd. ENLV.TA
Enlivex Therapeutics Ltd. CBI.TA
Clal Biotechnology Industries Ltd. GEFR.TA
Geffen Residence & Renewal Ltd BLRX.TA
BioLineRx Ltd. CANF.TA
Can-Fite BioPharma Ltd.
Performance
Periode | GFC-M.TA | DNA.TA | KDST.TA | PLUR.TA | REKA.TA | ENLV.TA | CBI.TA | GEFR.TA | BLRX.TA | CANF.TA |
---|---|---|---|---|---|---|---|---|---|---|
6M | 9.17 % | 19.98 % | 34.20 % | 0.70 % | 2.58 % | 12.55 % | 4.69 % | 40.81 % | 31.25 % | -41.18 % |
YTD | 13.91 % | 33.59 % | 154.99 % | -8.49 % | -9.96 % | -9.99 % | 2.29 % | 22.43 % | -67.19 % | -47.37 % |
1Y | 5.56 % | 39.43 % | 295.62 % | -25.09 % | -13.80 % | -32.77 % | -10.97 % | 26.52 % | -83.46 % | -67.74 % |
3Y | 36.17 % | 7.73 % | 161.78 % | -30.17 % | -29.78 % | -75.20 % | -52.90 % | -0.24 % | -90.14 % | -89.58 % |
5Y | 17.70 % | 64.36 % | 22.20 % | -95.22 % | -55.81 % | -91.97 % | -80.74 % | -26.56 % | -94.34 % | -95.31 % |
10Y | 67.95 % | -53.52 % | -92.05 % | -97.33 % | -33.72 % | -96.31 % | -86.86 % | -60.24 % | -99.64 % | -99.87 % |
From the beginning | 184.16 % | -95.81 % | -91.17 % | -96.83 % | 180.71 % | -96.31 % | -96.51 % | -91.11 % | -99.96 % | -99.97 % |